ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAMUEL ROMERO-RAMOS M.D.

Internal Medicine

13,297

$1.38M

672
562 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$104
Average prescription price

Avg: $67

PRASUNA DUBAGUNTA MD

Internal Medicine

2,569

$254K

132
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$99
Average prescription price

Avg: $67

ANDRES ELIZONDO M.D.

Internal Medicine

6,217

$341K

224
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

MANUEL CARRASCO-SANTIAGO MD

Internal Medicine

6,971

$336K

234
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

35%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

VIRENDRA AGARWAL MD

Internal Medicine

7,718

$349K

218
154 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $67

PRECHA SUVUNRUNGSI MD

Internal Medicine

12,483

$857K

304
206 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

EMMANUEL ORIAHI M.D.

Internal Medicine

4,612

$247K

196
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

IKENNA ADUGBA M.D.

Internal Medicine

9,552

$704K

378
148 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

PAUL STOUFFLET M.D.

Internal Medicine

7,593

$555K

322
182 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

MIHAELA SHUAIB MD

Internal Medicine

8,391

$1.14M

287
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 27%

$136
Average prescription price

Avg: $67

MYTRANG TRAN MD

Internal Medicine

5,380

$585K

230
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$109
Average prescription price

Avg: $67

DIETER MARTIN MD

Internal Medicine

23,891

$1.73M

583
497 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

SAMUEL MITZ MD

Internal Medicine

13,270

$810K

299
247 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

39%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

JOSE MARTINEZ MD

Internal Medicine

10,808

$1.04M

500
397 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$96
Average prescription price

Avg: $67

NARENDRA NIGALYE M.D.

Internal Medicine

11,713

$744K

363
239 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

35%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

MARY SNELLINGS M.D.

Internal Medicine

13,446

$825K

364
249 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

ARTHUR WILLIAMS MD

Internal Medicine

9,401

$431K

401
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

ELLEN REMENCHIK MD

Internal Medicine

8,901

$409K

326
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

ANDREW MERKIN MD

Internal Medicine

6,789

$505K

320
233 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

ANTONIO GAMBOA M.D.

Internal Medicine

5,429

$381K

207
162 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

DENISE BRUCKERHOFF D.O.

Internal Medicine

2,365

$127K

138
96 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

MARK HENNESSY M.D.

Internal Medicine

1,872

$116K

120
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

RENU DHAR MD

Internal Medicine

13,273

$755K

538
345 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

HIMA RAVI MD

Internal Medicine

14,997

$753K

526
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

CHRISTOPHER LOCKHART M.D.

Internal Medicine

34,128

$2.12M

834
700 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank